These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 29718854)

  • 1. Neurologic manifestations in anaphylaxis due to subcutaneous allergy immunotherapy: A case report.
    Mangold M; Qureshi M
    Medicine (Baltimore); 2018 May; 97(18):e0578. PubMed ID: 29718854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter real-world experience with epinephrine 0.5 mg dosing for anaphylaxis with allergen immunotherapy.
    Correa N; Quidwai A; Jeimy S; Rondilla N; White F; Moote W; Kuprowski M; Kim H
    Immunotherapy; 2021 Nov; 13(16):1325-1331. PubMed ID: 34612079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral immunotherapy for peanut allergy: multipractice experience with epinephrine-treated reactions.
    Wasserman RL; Factor JM; Baker JW; Mansfield LE; Katz Y; Hague AR; Paul MM; Sugerman RW; Lee JO; Lester MR; Mendelson LM; Nacshon L; Levy MB; Goldberg MR; Elizur A
    J Allergy Clin Immunol Pract; 2014; 2(1):91-6. PubMed ID: 24565775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiocontrast-induced anaphylaxis despite pretreatment and use of iso-osmolar contrast.
    Williams AN; Kelso JM
    Ann Allergy Asthma Immunol; 2007 Nov; 99(5):467-8. PubMed ID: 18051219
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment with a combination of omalizumab and specific immunotherapy for severe anaphylaxis after a wasp sting.
    Palgan K; Bartuzi Z; Gotz-Zbikowska M
    Int J Immunopathol Pharmacol; 2014; 27(1):109-12. PubMed ID: 24674685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AAAAI/ACAAI Subcutaneous Immunotherapy Surveillance Study (2013-2017): Fatalities, Infections, Delayed Reactions, and Use of Epinephrine Autoinjectors.
    Epstein TG; Liss GM; Berendts KM; Bernstein DI
    J Allergy Clin Immunol Pract; 2019; 7(6):1996-2003.e1. PubMed ID: 30776526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic Allergic Reactions and Anaphylaxis Associated with Allergen Immunotherapy.
    Dhamija Y; Epstein TEG; Bernstein DI
    Immunol Allergy Clin North Am; 2022 Feb; 42(1):105-119. PubMed ID: 34823741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of allergen immunotherapy in North America from 2008-2017: Lessons learned from the ACAAI/AAAAI National Surveillance Study of adverse reactions to allergen immunotherapy.
    Bernstein DI; Epstein TEG
    Allergy Asthma Proc; 2020 Mar; 41(2):108-111. PubMed ID: 32122446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prehospital Administration of Epinephrine in Pediatric Anaphylaxis.
    Carrillo E; Hern HG; Barger J
    Prehosp Emerg Care; 2016; 20(2):239-44. PubMed ID: 26555274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective study of epinephrine administration for anaphylaxis: how many doses are needed?
    Korenblat P; Lundie MJ; Dankner RE; Day JH
    Allergy Asthma Proc; 1999; 20(6):383-6. PubMed ID: 10624495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should Epinephrine Autoinjectors Be Prescribed to All Patients on Subcutaneous Immunotherapy?
    Fitzhugh DJ; Bernstein DI
    J Allergy Clin Immunol Pract; 2016; 4(5):862-7. PubMed ID: 27209596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of sublingual grass pollen immunotherapy after anaphylaxis.
    Nichani JR; de Carpentier J
    J Laryngol Otol; 2009 Jun; 123(6):683-4. PubMed ID: 18501039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of epinephrine and diphenhydramine rinses in decreasing local reactions to subcutaneous aeroallergen immunotherapy.
    Mustafa SS; Vadamalai K; Bingemann T; Ramsey A
    Allergy Asthma Proc; 2020 Jan; 41(1):52-58. PubMed ID: 31888783
    [No Abstract]   [Full Text] [Related]  

  • 14. Severe anaphylaxis to bee venom immunotherapy: efficacy of pretreatment and concurrent treatment with omalizumab.
    Galera C; Soohun N; Zankar N; Caimmi S; Gallen C; Demoly P
    J Investig Allergol Clin Immunol; 2009; 19(3):225-9. PubMed ID: 19610266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Speaking the same language: The World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System.
    Cox L; Larenas-Linnemann D; Lockey RF; Passalacqua G
    J Allergy Clin Immunol; 2010 Mar; 125(3):569-74, 574.e1-574.e7. PubMed ID: 20144472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anaphylactic reactions during immunotherapy.
    Rezvani M; Bernstein DI
    Immunol Allergy Clin North Am; 2007 May; 27(2):295-307, viii. PubMed ID: 17493504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse Events in Oral Immunotherapy for the Desensitization of Cow's Milk Allergy in Children: A Randomized Controlled Trial.
    De Schryver S; Mazer B; Clarke AE; St Pierre Y; Lejtenyi D; Langlois A; Torabi B; Zhao WW; Chan ES; Baerg I; Ben-Shoshan M
    J Allergy Clin Immunol Pract; 2019; 7(6):1912-1919. PubMed ID: 30776522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anaphylaxis: still a ghost behind allergen immunotherapy.
    Makatsori M; Calderon MA
    Curr Opin Allergy Clin Immunol; 2014 Aug; 14(4):316-22. PubMed ID: 24873937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcutaneous Immunotherapy Safety: Incidence per Surveys and Risk Factors.
    Sánchez-Borges M; Bernstein DI; Calabria C
    Immunol Allergy Clin North Am; 2020 Feb; 40(1):25-39. PubMed ID: 31761119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient Coagulopathy Due to Wasp Sting: A Case Report.
    Mong JS; Ooi CK
    J Emerg Med; 2017 Apr; 52(4):e115-e116. PubMed ID: 27998634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.